Gareth Morgan

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	88829	30115
h-endeksi	137	79
i10-endeksi	698	390

7000

3500

1750

5250

1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025234 285 302 387 417 562 672 899 1016 1323 1611 1693 2025 2104 2235 2673 3077 3462 4047 4146 4182 4644 4519 4450 5127 5936 6808 6255 5338 5179 568

Genel erişim

Tümünü görüntüle

249 makale

26 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Brian A WalkerIndiana Universityiu.edu üzerinde doğrulanmış e-posta adresine sahip
Gordon CookUniversity of Leedsleeds.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Martin KaiserProfessor of Haematology, Institute of Cancer Research Londonicr.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Christopher WardellAssistant Professor of Bioinformatics, University of Arkansas for Medical Sciencesuams.edu üzerinde doğrulanmış e-posta adresine sahip
Charlotte PawlynClinician Scientist, The Institute of Cancer Research, Londonicr.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Matthew JennerUniversity Hospital Southamptonuhs.nhs.uk üzerinde doğrulanmış e-posta adresine sahip
van rheeuams.edu üzerinde doğrulanmış e-posta adresine sahip
Hartmut GoldschmidtUniversitätsklinikum Heidelbergmed.uni-heidelberg.de üzerinde doğrulanmış e-posta adresine sahip
Carolina SchinkeUniversity of Arkansas for Medical Sciencesuams.edu üzerinde doğrulanmış e-posta adresine sahip
Nigel RussellHaematology . Guy’s Hospital, Londonnottingham.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Eileen M. BoyleNYU Langonenyulangone.org üzerinde doğrulanmış e-posta adresine sahip
sara rollinsonmanchester.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Cody AshbyAssistant Professor, University of Arkansas for Medical Sciencesuams.edu üzerinde doğrulanmış e-posta adresine sahip
David Gonzalez de CastroQueen's University Belfastqub.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Eve RomanProfessor of Epidemiologyyork.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Michele CavoProfessor of Hematologyunibo.it üzerinde doğrulanmış e-posta adresine sahip
Antonio PalumboUniversità di Torino; Torino Italyunito.it üzerinde doğrulanmış e-posta adresine sahip
Jesús San Miguel ORCID 0000-0002-...Director de Medicina Clínica y Traslacional de la Universidad de Navarra, Director Médico de la CUNunav.es üzerinde doğrulanmış e-posta adresine sahip
Ola Landgrenmiami.edu üzerinde doğrulanmış e-posta adresine sahip
Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, School of Medicinemed.uoa.gr üzerinde doğrulanmış e-posta adresine sahip

Takip et

Gareth Morgan

NYU

nyulangone.org üzerinde doğrulanmış e-posta adresine sahip

myeloma genetics and treatment


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
International staging system for multiple myeloma PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ... Journal of clinical oncology 23 (15), 3412-3420, 2005	3947	2005
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report … JJM Van Dongen, AW Langerak, M Brüggemann, PAS Evans, M Hummel, ... Leukemia 17 (12), 2257-2317, 2003	3713	2003
International uniform response criteria for multiple myeloma BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ... Leukemia 20 (9), 1467-1473, 2006	3574	2006
The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report BA Swinburn, VI Kraak, S Allender, VJ Atkins, PI Baker, JR Bogard, ... The lancet 393 (10173), 791-846, 2019	3122	2019
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ... Journal of clinical oncology 33 (26), 2863-2869, 2015	2442	2015
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma JA Child, GJ Morgan, FE Davies, RG Owen, SE Bell, K Hawkins, J Brown, ... New England Journal of Medicine 348 (19), 1875-1883, 2003	2357	2003
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma FE Davies, N Raje, T Hideshima, S Lentzsch, G Young, YT Tai, B Lin, ... Blood, The Journal of the American Society of Hematology 98 (1), 210-216, 2001	1242	2001
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009	1230	2009
The genetic architecture of multiple myeloma GJ Morgan, BA Walker, FE Davies Nature Reviews Cancer 12 (5), 335-348, 2012	1162	2012
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ... Leukemia 23 (2), 215-224, 2009	1072	2009
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ... Leukemia 22 (2), 414-423, 2008	1051	2008
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012	995	2012
Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults CF Skibola, MT Smith, E Kane, E Roman, S Rollinson, RA Cartwright, ... Proceedings of the National Academy of Sciences 96 (22), 12810-12815, 1999	720	1999
Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ... Journal of clinical oncology 33 (33), 3911-3920, 2015	672	2015
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial GJ Morgan, FE Davies, WM Gregory, K Cocks, SE Bell, AJ Szubert, ... The Lancet 376 (9757), 1989-1999, 2010	638	2010
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical … BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, G Morgan, ... Journal of clinical oncology 23 (36), 9219-9226, 2005	631	2005
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ... The Hematology Journal 4 (6), 379-398, 2003	629	2003
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000	611	2000
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study AC Rawstron, JA Child, RM de Tute, FE Davies, WM Gregory, SE Bell, ... Journal of clinical oncology 31 (20), 2540-2547, 2013	500	2013
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ... Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011	484	2011

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar